Baird Financial Group
CRNX icon

Baird Financial Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Baird Financial Group’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,749
Closed -$243K – 1766
2024
Q4 		$243K Buy
4,749
+279
+6% +$14.3K ﹤0.01% 1628
2024
Q3 		$228K Hold
4,470
– – ﹤0.01% 1628
2024
Q2 		$200K Buy
+4,470
New +$200K ﹤0.01% 1681